Also in the previous clinical trial, we have demonstrated administration of GM-CSF is an effective strategy not only in immune modulation, but also in reduction of fungal infections due to neutropenia following hematopoietic stem cell transplantation (HSCT) conditioning (10). The gene discussed is CSF2; the disease is Decreased total neutrophil count.